Microbial Biotechnology
Microorganisms are performing many chemical reactions. This ability are often applied for the assembly of commercial chemicals. It provide solutions to efficiently convert
biomass into chemicals and fuels using microorganisms. Genetic techniques enable us to switch the
microbial metabolism. Our objective is to adapt the
microbial metabolism, so that the product is produced at maximum theoretical yield, whereas also ATP is produced to support growth and maintenance.
Microbial biotechnology or industrial
microbiology is the use of microorganisms to obtain an economically valuable product or activity at a commercial or large scale. The microorganisms used in industrial processes are natural, laboratory-selected mutant or genetically engineered strains. Economically valuable products such as alcohols, solvents, organic acids, amino acids, enzymes, fermented dairy products, food additives, vitamins, antibiotics, recombinant proteins and hormones, biopolymers, fertilizers, and biopesticides are produced by microorganisms that are used in chemical, food, pharmaceutical, agricultural, and other industries.
Biodegradation and
biotransformation of complex compounds, domestic and industrial wastewater treatment, biomining, and
enhanced oil recovery are samples of microbially valuable activities. According to the UN Convention on Biological Diversity,
microbial biotechnology are often dened as any technological application that uses microbiological systems,
microbial organisms, or derivatives thereof, to form or modify products or processes for specic use.
High Impact List of Articles
-
Anti-PDL-1 response in metastatic soft tissue angiosarcoma: Clinical case and systematic review
MO Angel, FD Waisberg, P Mando, MR Chacon and RD Chacon
Review Article: Clinical Practice
-
Anti-PDL-1 response in metastatic soft tissue angiosarcoma: Clinical case and systematic review
MO Angel, FD Waisberg, P Mando, MR Chacon and RD Chacon
Review Article: Clinical Practice
-
Practical approaches to the treatment of atrial fibrillation: focus on stroke prevention using oral anticoagulant drugs
Tatjana S Potpara, Marina M Licina, Marija M Polovina
Review Article: Clinical Practice
-
Practical approaches to the treatment of atrial fibrillation: focus on stroke prevention using oral anticoagulant drugs
Tatjana S Potpara, Marina M Licina, Marija M Polovina
Review Article: Clinical Practice
-
EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial
Geoffrey Y Ku and Gilberto de Lima Lopes Jr
Review Article: Clinical Practice
-
EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial
Geoffrey Y Ku and Gilberto de Lima Lopes Jr
Review Article: Clinical Practice
-
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Bo Ahraain
Drug Evaluation: Clinical Practice
-
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Bo Ahraain
Drug Evaluation: Clinical Practice
-
Effects of Lycium barbarum L. root bark extract on alloxan-induced diabetic mice
Dawei Gao, Qingwang Li, Zhiwei Liu, Ying Li, Zhihua Liu, Yusheng Fan, Zengsheng Han and Jian Li1
Research Article: Clinical Practice
-
Effects of Lycium barbarum L. root bark extract on alloxan-induced diabetic mice
Dawei Gao, Qingwang Li, Zhiwei Liu, Ying Li, Zhihua Liu, Yusheng Fan, Zengsheng Han and Jian Li1
Research Article: Clinical Practice
-
Antibiotic resistance: what have we learned and where do we go from here?
Joseph Blondeau
Interview: Clinical Practice
-
Antibiotic resistance: what have we learned and where do we go from here?
Joseph Blondeau
Interview: Clinical Practice
Relevant Topics in Clinical